semaglutide stock photo Images Overweight woman preparing GLP-1 agonist

The study says that GLP-1 usage was associated with a 37 per cent higher risk of alopecia compared with SGLT-2 inhibitors and a 68 per cent higher risk than those who use DPP-4 inhibitors

If the medication is cloudy or has particles in it, discard the pen without using it

It's common not to see significant weight loss in the first 46 weeks this is normal and expected as the medication builds up

This limits generalizability and does not mirror most of the type 1 diabetes patients seen in nephrology practice

For emergency or urgent procedures, surgery typically proceeds with appropriate precautions according to local policy